Mesalamine Kit
Product Images NDC 45802-923

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 45802-923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Image (Image 01)

FDA Label Image

Remove The Bottles Image (Image 02)

FDA Label Image

Prepare The Medication For Administration Image (Image 03)

FDA Label Image

Assume The Correct Body Position Image #1 (Image 04)

FDA Label Image

Assume The Correct Body Position Image #2 (Image 05)

FDA Label Image

Administer The Medication Image (Image 06)

FDA Label Image

Image 07

Image 07
This text provides instructions for inserting the serial number, lot number, and expiration date of a product.*
FDA Label Image

Image 08

Image 08
This product is a rectal suspension, used in enema form and is available for prescription only. Mesalamine is the key ingredient and is present in a quantity of 4 grams in each unit-dose. The package contains 7 unit-dose bottles of 60 mL each. In addition, the package contains 7 cleansing wipes. The product should be dispensed in unopened packaging without repackaging. The product requires shaking well before use. The usual dose may vary and should be prescribed by the physician. The product may cause stains and should be kept away from children. The recommended storage temperature is 20.25°C. The product's content may darken over time. It is manufactured by Allegan, M.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.